Global dialyzer reprocessing machines market is expected to reach USD 127,076.75 million by 2030 from USD 96,758.10 million in 2022, growing at a CAGR of 3.5% during the forecast period of 2023 to 2033.
Market Segmentation
Global Dialyzer Reprocessing Machines Market, By Type (Automatic and Semi-Automatic), Modality (Benchtop and Standalone), Station Type (Single Station and Dual Station), End User (Hospitals, Dialysis Centers, and Home Use), Country (U.S., Canada, Mexico, Germany, Italy, Spain, Russia, Turkey, Belgium, Rest of Europe, China, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, Egypt, Israel, and the Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Overview of Global Dialyzer Reprocessing Machines Market Dynamics
- Driver
- Increasing prevalence of end-stage renal disease (ESRD)
- Restraint
- Stringent regulations for approval
- Opportunity
- Rise in technological advancements
Market Players
Some of the major market players operating in the global dialyzer reprocessing machines market are:
- Anjue Medical Equipment Co., Ltd.
- Geryfalcon Healthcare Pvt. Ltd
- Saubern
- WESLEY BIOTECH
- P.K. Scientific & Chemicals
- Cliniva Healthcare
- Atlantic Biomedical
- Advin Health Care
- MEDIVATORS Inc. (Subsidiary of STERIS)
- Nanotech
- LABSMED
- Hemant Surgical Industries Ltd
- Others
TABLE OF CONTENTS
1 INTRODUCTION 26
- 1.1 OBJECTIVES OF THE STUDY 26
- 1.2 MARKET DEFINITION 26
- 1.3 OVERVIEW OF THE GLOBAL DIALYZER REPROCESSING MACHINES MARKET 26
- 1.4 LIMITATIONS 27
- 1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
- 2.1 MARKETS COVERED 30
- 2.2 GEOGRAPHICAL SCOPE 31
- 2.3 YEARS CONSIDERED FOR THE STUDY 32
- 2.4 CURRENCY AND PRICING 32
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 33
- 2.6 MULTIVARIATE MODELLING 36
- 2.7 TYPE LIFELINE CURVE 36
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
- 2.9 DBMR MARKET POSITION GRID 38
- 2.10 MARKET END USER COVERAGE GRID 39
- 2.11 VENDOR SHARE ANALYSIS 40
- 2.12 SECONDARY SOURCES 41
- 2.13 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
- 4.1 PESTEL ANALYSIS 48
- 4.2 PORTER'S FIVE FORCES MODEL 49
- 4.3 STRATEGIC INITIATIVES 50
5 GLOBAL DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 51
- 5.1 REGULATORY SCENARIO IN THE U.S 51
- 5.2 REGULATORY SCENARIO IN CHINA 52
- 5.3 REGULATORY SCENARIO IN AUSTRALIA 52
6 MARKET OVERVIEW 54
- 6.1 DRIVERS 56
- 6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 56
- 6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 56
- 6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 57
- 6.2 RESTRAINTS 58
- 6.2.1 STRINGENT REGULATIONS FOR APPROVAL 58
- 6.2.2 POSSIBLE RISK OF INFECTIONS 58
- 6.3 OPPORTUNITIES 59
- 6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 59
- 6.3.2 INCREASING FOCUS ON INFECTION CONTROL 60
- 6.4 CHALLENGES 60
- 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 60
- 6.4.2 LACK OF STANDARDIZATION 61
7 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 62
- 7.1 OVERVIEW 63
- 7.2 SEMI-AUTOMATIC 66
- 7.3 AUTOMATIC 67
8 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 68
- 8.1 OVERVIEW 69
- 8.2 BENCHTOP 72
- 8.2.1 SEMI-AUTOMATIC 73
- 8.2.2 AUTOMATIC 73
- 8.3 STANDALONE 73
- 8.3.1 SEMI-AUTOMATIC 74
- 8.3.2 AUTOMATIC 74
9 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 75
- 9.1 OVERVIEW 76
- 9.2 DUAL STATION 79
- 9.3 SINGLE STATION 80
10 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY END USER 81
- 10.1 OVERVIEW 82
- 10.2 DIALYSIS CENTERS 85
- 10.3 HOSPITAL 86
- 10.4 HOME USE 87
11 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY REGION 88
- 11.1 OVERVIEW 89
- 11.2 NORTH AMERICA 94
- 11.2.1 U.S. 101
- 11.2.2 CANADA 103
- 11.2.3 MEXICO 105
- 11.3 EUROPE 107
- 11.3.1 GERMANY 114
- 11.3.2 ITALY 116
- 11.3.3 SPAIN 118
- 11.3.4 RUSSIA 120
- 11.3.5 TURKEY 122
- 11.3.6 BELGIUM 124
- 11.3.7 REST OF EUROPE 126
- 11.4 ASIA-PACIFIC 127
- 11.4.1 CHINA 134
- 11.4.2 INDIA 136
- 11.4.3 AUSTRALIA 138
- 11.4.4 SINGAPORE 140
- 11.4.5 THAILAND 142
- 11.4.6 MALAYSIA 144
- 11.4.7 INDONESIA 146
- 11.4.8 PHILIPPINES 148
- 11.4.9 VIETNAM 150
- 11.4.10 REST OF ASIA-PACIFIC 152
- 11.5 SOUTH AMERICA 153
- 11.5.1 BRAZIL 160
- 11.5.2 ARGENTINA 162
- 11.5.3 REST OF SOUTH AMERICA 164
- 11.6 MIDDLE EAST AND AFRICA 165
- 11.6.1 SAUDI ARABIA 172
- 11.6.2 EGYPT 174
- 11.6.3 ISRAEL 176
- 11.6.4 REST OF MIDDLE EAST AND AFRICA 178
12 GLOBAL DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 179
- 12.1 COMPANY SHARE ANALYSIS: GLOBAL 179
- 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 180
- 12.3 COMPANY SHARE ANALYSIS: EUROPE 181
- 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 182
13 SWOT ANALYSIS 183
14 GLOBAL DIALYZER REPROCESSING MACHINES MARKET 184
- 14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 184
- 14.1.1 COMPANY SNAPSHOT 184
- 14.1.2 REVENUE ANALYSIS 184
- 14.1.3 COMPANY SHARE ANALYSIS 185
- 14.1.4 PRODUCT PORTFOLIO 185
- 14.1.5 RECENT DEVELOPMENTS 185
- 14.2 HEMANT SURGICAL INDUSTRIES LTD. 186
- 14.2.1 COMPANY SNAPSHOT 186
- 14.2.2 REVENUE ANALYSIS 186
- 14.2.3 COMPANY SHARE ANALYSIS 187
- 14.2.4 PRODUCT PORTFOLIO 187
- 14.2.5 RECENT DEVELOPMENTS 187
- 14.3 SAUBERN 188
- 14.3.1 COMPANY SNAPSHOT 188
- 14.3.2 COMPANY SHARE ANALYSIS 188
- 14.3.3 PRODUCT PORTFOLIO 189
- 14.3.4 RECENT DEVELOPMENTS 189
- 14.4 P.K. SCIENTIFIC & CHEMICALS 190
- 14.4.1 COMPANY SNAPSHOT 190
- 14.4.2 PRODUCT PORTFOLIO 190
- 14.4.3 RECENT DEVELOPMENT 190
- 14.5 LABSMED. 191
- 14.5.1 COMPANY SNAPSHOT 191
- 14.5.2 COMPANY SHARE ANALYSIS 191
- 14.5.3 PRODUCT PORTFOLIO 192
- 14.5.4 RECENT DEVELOPMENTS 192
- 14.6 ATLANTIC BIOMEDICAL 193
- 14.6.1 COMPANY SNAPSHOT 193
- 14.6.2 COMAPYN SHARE ANALYSIS 193
- 14.6.3 PRODUCT PORTFOLIO 194
- 14.6.4 RECENT DEVELOPMENT 194
- 14.7 ADVIN HEALTH CARE 195
- 14.7.1 COMPANY SNAPSHOT 195
- 14.7.2 PRODUCT PORTFOLIO 195
- 14.7.3 RECENT DEVELOPMENTS 195
- 14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 196
- 14.8.1 COMPANY SNAPSHOT 196
- 14.8.2 PRODUCT PORTFOLIO 196
- 14.8.3 RECENT DEVELOPMENT 196
- 14.9 CLINIVA HEALTHCARE 197
- 14.9.1 COMPANY SNAPSHOT 197
- 14.9.2 PRODUCT PORTFOLIO 197
- 14.9.3 RECENT DEVELOPMENT 197
- 14.10 GERYFALCON HEALTHCARE PVT. LTD. 198
- 14.10.1 COMPANY SNAPSHOT 198
- 14.10.2 PRODUCT PORTFOLIO 198
- 14.10.3 RECENT DEVELOPMENT 198
- 14.11 NANOTECH 199
- 14.11.1 COMPANY SNAPSHOT 199
- 14.11.2 PRODUCT PORTFOLIO 199
- 14.11.3 RECENT DEVELOPMENTS 199
- 14.12 WESLEY BIOTECH 200
- 14.12.1 COMPANY SNAPSHOT 200
- 14.12.2 PRODUCT PORTFOLIO 200
- 14.12.3 RECENT DEVELOPMENT 200
15 QUESTIONNAIRE 201
16 RELATED REPORTS 204